The Factors such as the rising proteomics research, increase in research activities in the pharmaceutical and biotechnology sector and the rising prevalence of cancer.
According to the new market research report Stable Isotope Labeled Compounds Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019.
Based on application, the Stable Isotope Labeled Compound Market is segmented into clinical diagnostics, research, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2019, owing to rising research activities in the biomedical, environmental, pharmaceutical & ecological, and agricultural sectors.
The prominent players in this market include PerkinElmer Inc. (US), Merck KGaA (Germany), URENCO Limited (UK), IsoSciences, LLC (US), Cambridge Isotope Laboratories, Inc. (US), Medical Isotopes, Inc. (US), Trace Sciences International (US), Omicron Biochemicals, Inc. (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199